Somatostatinoma
ORPHA:97283DiseaseUnknownAdult, Elderly
Фенотипы (HPO)35
Частый (30–79%)15
HP:0000819Diabetes mellitus
HP:0001824Weight loss
HP:0002014Diarrhea
HP:0002017Nausea and vomiting
HP:0002019Constipation
HP:0002039Anorexia
HP:0002240Hepatomegaly
HP:0002570Steatorrhea
HP:0002574Episodic abdominal pain
HP:0002894Neoplasm of the pancreas
HP:0004396Poor appetite
HP:0004840Hypochromic microcytic anemia
HP:0005609Gallbladder dysfunction
HP:0012432Chronic fatigue
HP:0100833Neoplasm of the small intestine
Периодический (5–29%)8
HP:0001046Intermittent jaundice
HP:0001406Intrahepatic cholestasis
HP:0001438Abnormality of abdomen morphology
HP:0001541Ascites
HP:0002239Gastrointestinal hemorrhage
HP:0005214Intestinal obstruction
HP:0012334Extrahepatic cholestasis
HP:0030145Lack of bowel sounds
Очень редкий (1–4%)12
HP:0000820Abnormality of the thyroid gland
HP:0000837Increased circulating gonadotropin level
HP:0000845Elevated circulating growth hormone concentration
HP:0000870Increased circulating prolactin concentration
HP:0001031Subcutaneous lipoma
HP:0002865Medullary thyroid carcinoma
HP:0002893Pituitary adenoma
HP:0002897Parathyroid adenoma
HP:0003072Hypercalcemia
HP:0003118Increased circulating cortisol level
HP:0008200Primary hyperparathyroidism
HP:0008256Adrenocortical adenoma
Эпидемиология2
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | <1 / 1 000 000 | 0.0025 | Europe | Value and class |
| Point prevalence | <1 / 1 000 000 | — | Europe | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)